Point-of-Care HCV Test Receives FDA Marketing Greenlight
The FDA has authorized Cepheid’s Xpert HCV test and GeneXpert Xpress System, the first point-of-care HCV test for certified settings.
Read MorePosted by Chris Wolski | Jun 28, 2024 | POC Reagents & Test Kits |
The FDA has authorized Cepheid’s Xpert HCV test and GeneXpert Xpress System, the first point-of-care HCV test for certified settings.
Read MorePosted by Andy Lundin | Jun 12, 2024 | Covid 19 |
A new study found that at-home antibody tests can effectively detect inadequate COVID immunity, aiding decisions about booster vaccinations.
Read MorePosted by Andy Lundin | Jun 5, 2024 | Molecular Diagnostics |
Researchers developed a new DNA amplification method that offers a faster and more reliable alternative to the PCR method.
Read MorePosted by Andy Lundin | May 30, 2024 | Infectious Diseases |
A report shows that on-site pathology tests for infectious diseases in rural and remote areas can be as reliable as hospital lab tests.
Read MorePosted by Eli Patterson | Apr 23, 2024 | Coagulation Testing, Webcasts |
Join our webinar to learn how aligning clinical and laboratory practices using the Quantra Hemostasis System can dramatically improve management of critical bleeding. Gain insights on viscoelastic testing, rapid identification of acute coagulopathy, and effective team collaboration. Perfect for technicians, lab managers, and healthcare providers.
Read More